When One Substance Policy Changes Another Substance Use
medical cannabis research: A 95 study systematic review finds tobacco, cannabis, and alcohol policies often spill across substances, but substitution, complementarity, and independence vary by policy type and population. It keeps the evidence readable…
When Tobacco, Cannabis, and Alcohol Policies Spill Over Into Each Other
medical cannabis research: A 95-study systematic review finds that tobacco, cannabis, and alcohol policies often influence use of other substances, but the direction depends on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Alcohol, and Tobacco Policies Collide
medical cannabis research: A 95-study systematic review finds that substance policies often spill across cannabis, alcohol, and tobacco use, but the direction depends heavily on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Tobacco, and Alcohol Policies Collide
medical cannabis research: A 95-study systematic review finds that policies aimed at one substance often influence use of others, but the direction of change depends heavily on policy type, population, and context. It keeps the evidence readable for…
Cannabis Use and Suicidal Behaviour in Young Adults Across Washington State and Victoria
medical cannabis research: A longitudinal cohort study linked young adult cannabis use with later suicidal behaviour, while also showing that legalization context alone did not explain regional suicide risk patterns. It keeps the evidence readable for…
Cannabis and Violence Risk: What a Large Meta-analysis Really Shows
medical cannabis research: A 63-study meta-analysis found higher odds of violence perpetration and victimization among cannabis users, but the clinical meaning depends heavily on confounding, dose, psychiatric risk, and study design. It keeps the…
Medical Cannabis Dose and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest low daily THC doses may relate to better anxiety and insomnia scores in pancreatic cancer, but missing data and small sample size require careful interpretation. It keeps the evidence readable for…
Medical Cannabis Dose Patterns and Symptom Control in Pancreatic Cancer
medical cannabis research: CANPAN pilot data suggest modest THC dosing may relate to anxiety, insomnia, and multi-symptom improvement in pancreatic cancer, while also exposing major feasibility challenges in advanced cancer research. It keeps the…
What CANPAN Suggests About THC Dose and Symptoms in Pancreatic Cancer
medical cannabis research: A small CANPAN analysis links higher daily THC exposure with better anxiety and insomnia scores in pancreatic cancer, while also exposing major feasibility and missing-data challenges for future trials. It keeps the evidence…
Intranasal lipid carrier cannabidiol for Dravet and Lennox-Gastaut syndromes remains promising but unproven
medical cannabis research: A new review argues that intranasal nanostructured lipid carrier CBD could improve brain delivery for severe pediatric epilepsies, but the evidence remains preclinical and not yet patient-ready. It keeps the evidence readable…